Antigen News and Research

RSS

New case study shows CAR T therapy as viable option for AML patients

Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.

9 May 2018

New chemical trap catches trace glycoproteins, shows promise for targeted cancer treatments

Cancer drops sparse chemical hints of its presence early on, but unfortunately, many of them are in a class of biochemicals that could not be detected thoroughly, until now.

8 May 2018

Study identifies new biomarker for early lung cancer diagnosis

High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.

8 May 2018

NucleoBio's new test kit could accurately reveal results of prostate cancer screening

Recognizing that prostate cancer in men is misdiagnosed, NucleoBio Inc. is developing a new product, Prostac, that will accurately reveal results of a prostate cancer screening.

4 May 2018

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to how primed patients' immune systems are before the therapy is administered.

30 Apr 2018

Researchers uncover the mystery of B cell receptors

When a pathogen evades or overcomes our innate immune defenses, the adaptive immune system kicks into action. There are two types of adaptive immune responses: cell-mediated immunity mediated by T cells and humoral immunity mediated by antibodies produced by B cells.

27 Apr 2018

New CAR-T therapy could provide safer, more effective cancer treatment

There have been few cancer treatments with such a promising future as using the patient's own immune system.

27 Apr 2018

Doctors cure sickle cell patients using allogeneic stem cells

Seven adults with sickle cell disease have been cured by doctors at the University of Illinois Hospital, thanks to the development of a new protocol for stem cell transplantation.

25 Apr 2018

Shorter courses of radiotherapy found to be safe, effective for prostate cancer patients

Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients, according to research presented at the ESTRO 37 conference today.

23 Apr 2018

AYOXXA launches advanced low-volume beads-on-a-chip multiplex protein analysis system

AYOXXA Biosystems GmbH, an international biotechnology company, today announces the introduction of its advanced low-volume beads-on-a-chip multiplex protein analysis system. The LUNARIS™ system can be readily integrated into any laboratory routine and is optimized to provide easy-to-use, standardized workflow from sample to result.

20 Apr 2018

Interaction between dioxin and HLA gene variant activates events associated with rheumatoid arthritis

It has been known for more than three decades that individuals with a particular version of a gene - human leukocyte antigen (HLA) - have an increased risk for rheumatoid arthritis.

19 Apr 2018

Innovative device shows promise in capturing and releasing circulating tumor cells

For years, bioengineer Yaling Liu has been in pursuit of the deadly tumor cell. Liu has been perfecting a microfluidic device the size of two quarters that has the ability to catch and release circulating tumor cells (CTCs)--cancer cells that circulate in a cancer patient's blood.

19 Apr 2018

Environmental pollutants found to worsen rheumatoid arthritis

Scientists have uncovered a link between the risk of developing rheumatoid arthritis and environmental pollutants, such as cigarette smoke.

19 Apr 2018

New microscopy techniques allow quasi-biochemical studies on living T cells

A joint study by the TU Wien and the Vienna School of Medicine has now led to a surprising result. While most opinion leaders in the field reasoned that T cell receptors must interact with one another for effective immune-signaling, the Viennese study shows: T cell receptors act alone. The study has now been published in the journal Nature Immunology.

19 Apr 2018

Engineered immune cells clear deadly pediatric brain tumor in mice

Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University School of Medicine has demonstrated.

16 Apr 2018

Research reveals immune suppressive role of soluble antibodies in tumor progression

Wistar researchers have found that soluble antibodies promote tumor progression by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in pre-clinical cancer models. Results were published online in Cancer Immunology Research.

13 Apr 2018

Nanotechnology-based treatment approach shown to be effective in mouse models of lung cancer

The most common type of lung cancer, non-small cell lung cancer (NSCLC), continues to be difficult to treat, with five year survival rates of about 36 percent for stage 3A tumors.

11 Apr 2018

Research identifies link between rare gene variants and survival after blood and marrow transplant

Blood and marrow transplant, or BMT, is a lifesaving and effective treatment for many patients, but the procedure can cause serious and life-threatening complications.

10 Apr 2018

Theresa May to launch £75m drive against prostate cancer

British Prime Minister Theresa May has declared war against prostate cancer. Yearly, 47,000 men are UK are diagnosed with this cancer and 11,000 succumb to it, according to reports. Recent reports show that prostate cancer in men kills more than breast cancer does in women.

10 Apr 2018

Prostate cancer on the rise and detected late in the UK finds report

As many as 37 percent of all prostate cancers are detected late or in advanced stages in the UK, finds a new report from the charity Orchid. The report suggests that most of these cancers are detected at stages 3 and 4. Statistics show that nearly 47,000 men are diagnosed with prostate cancer annually and 11,000 succumb to the disease each year.

9 Apr 2018

Antigen News and Research

New case study shows CAR T therapy as viable option for AML patients

New chemical trap catches trace glycoproteins, shows promise for targeted cancer treatments

Study identifies new biomarker for early lung cancer diagnosis

NucleoBio's new test kit could accurately reveal results of prostate cancer screening

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Researchers uncover the mystery of B cell receptors

New CAR-T therapy could provide safer, more effective cancer treatment

Doctors cure sickle cell patients using allogeneic stem cells

Shorter courses of radiotherapy found to be safe, effective for prostate cancer patients

AYOXXA launches advanced low-volume beads-on-a-chip multiplex protein analysis system

Interaction between dioxin and HLA gene variant activates events associated with rheumatoid arthritis

Innovative device shows promise in capturing and releasing circulating tumor cells

Environmental pollutants found to worsen rheumatoid arthritis

New microscopy techniques allow quasi-biochemical studies on living T cells

Engineered immune cells clear deadly pediatric brain tumor in mice

Research reveals immune suppressive role of soluble antibodies in tumor progression

Nanotechnology-based treatment approach shown to be effective in mouse models of lung cancer

Research identifies link between rare gene variants and survival after blood and marrow transplant

Theresa May to launch £75m drive against prostate cancer

Prostate cancer on the rise and detected late in the UK finds report

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics